酰胺质子转移加权MRI预测膀胱癌组织学分级
这项单中心前瞻性研究纳入83例未经治疗、病灶大于10 mm且MRI质量合格的膀胱癌患者,术前用酰胺质子转移加权(APTw)MRI和扩散加权成像(DWI)测量肿瘤定量参数,评估其区分低级别与高级别膀胱癌的诊断性能。
要点
- 高级别膀胱癌APTw值高于低级别(6% vs 2%),ADC值低于低级别(0.92 vs 1.21×10⁻³ mm²/sec)。
- APTw与ADC单独区分低级别与高级别膀胱癌的AUC均为0.84,两者差异无统计学意义(P=0.94)。
- APTw与ADC联合可将AUC提升至0.93,提示联合应用有助提高组织学分级诊断性能。
核心结论
- 酰胺质子转移加权MRI与扩散加权成像联合应用,有潜力通过区分低级别与高级别膀胱癌来改善膀胱癌的组织学特征评估。
研究设计与样本
- 单中心前瞻性研究,于2020年7月至2021年9月在大学教学医院纳入83例经病理分析证实、无既往治疗、病灶大于10 mm且MRI质量合格的膀胱癌参与者,术前行包括APTw MRI和DWI在内的多参数MRI,由两名放射科医师独立测量原发肿瘤的平均APTw值和表观扩散系数(ADC)值,并以病理分析为参考标准。
关键影像表现/征象
- 高级别膀胱癌的APTw值为6%(四分位距4%-12%),低级别为2%(四分位距1%-3%),高级别高于低级别(P<.001)。
- 高级别膀胱癌的ADC值为0.92×10⁻³ mm²/sec±0.17,低级别为1.21×10⁻³ mm²/sec±0.25,高级别低于低级别(P<.001)。
诊断标准与关键数值
- APTw区分低级别与高级别膀胱癌的AUC为0.84。
- ADC区分低级别与高级别膀胱癌的AUC为0.84,与APTw相比差异无统计学意义(P=.94)。
- APTw与ADC联合区分低级别与高级别膀胱癌的AUC为0.93,与单独应用相比差异有统计学意义(均P=.01)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Background Bladder cancer is classified into high and low grades with different clinical treatments and prognoses. Thus, accurate preoperative evaluation of the histologic grade through imaging techniques is essential. Purpose To investigate the potential of amide proton transfer-weighted (APTw) MRI in evaluating the grade of bladder cancer and to evaluate whether APTw MRI can add value to diffusion-weighted imaging (DWI) at MRI. Materials and Methods In this single-center prospective study, participants with pathologic analysis-confirmed bladder cancer with no previous treatment, lesions larger than 10 mm, and adequate MRI quality were enrolled from July 2020 to September 2021 in a university teaching hospital. All participants underwent preoperative multiparametric MRI, including APTw MRI and DWI. The mean APTw and apparent diffusion coefficient (ADC) values of the primary tumor were measured independently by two radiologists. Receiver operating characteristic curves were generated to evaluate the diagnostic performance of these quantitative parameters. Results In total, 83 participants (mean age, 64 years ± 13 [SD]; 72 men) were evaluated: 51 with high-grade and 32 with low-grade bladder cancer. High-grade bladder cancer showed higher APTw values (6% [IQR, 4%-12%] vs 2% [IQR, 1%-3%]; P < .001) and lower ADC values (0.92 × 10-3 mm2/sec ± 0.17 vs 1.21 × 10-3 mm2/sec ± 0.25; P < .001) than low-grade bladder cancer. The area under the receiver operating characteristic curve (AUC) of APTw and ADC for differentiating low- and high-grade bladder cancer was similar (0.84 for both; P = .94). Moreover, the combination of the two techniques improved the diagnostic performance (AUC, 0.93; all P = .01). Conclusion The combination of amide proton transfer-weighted and diffusion-weighted MRI has the potential to improve the histologic characterization of bladder cancer by differentiating low- from high-grade cancers. © RSNA, 2022 Online supplemental material is available for this article. See also the editorial by Milot in this issue. An earlier incorrect version appeared online. This article was corrected on July 7, 2022.
引用
- Wang, Cai, Huang, et al. Amide Proton Transfer-weighted MRI in Predicting Histologic Grade of Bladder Cancer. Radiology. 2022. PMID: 35762886. doi:10.1148/radiol.211804
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。